Publication: I Am Biotech

First reported 20 hours ago - Updated 20 hours ago - 1 reports

Innovative Companies and Investment Trends in Clean Tech at BIO World Congress

A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 as deals are happening and attractive returns are generated. According to Reuters, “biotech IPOs have turned in a strong performance, delivering an average return of ... [Published I Am Biotech - 20 hours ago]

Entities: Clean Technology, Brent Erickson, Biotechnology, Evolva, Renewable Chemicals

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Plastics

Roundtable Discussion Highlights Innovation, Commercial Reality for Renewable Chemical Products

Last week BIO brought together representatives from five renewable chemical companies that will be speaking at BIO’s World Congress on Industrial Biotechnology next month in Montreal for a roundtable discussion highlighting developments in the renewable ... [Published I Am Biotech - May 22 2013]

Entities: Renewable Chemicals, Plastics, Carbon Dioxide

First reported May 21 2013 - Updated May 22 2013 - 1 reports

Angelina Jolie

Gene Patents, Angelina Jolie, and Reality

By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Angelina Jolie recently announced her personal connection with breast cancer and Myriad’s BRCA genetic test. While Jolie’s post was a ... [Published I Am Biotech - May 21 2013]

Entities: Angelina Jolie, Hans Sauer, Patient, Breast Cancer

First reported May 21 2013 - Updated May 21 2013 - 1 reports

BIO Convention Post-Con, Plus a Look Ahead

Last month, the biopharma community gathered for the industry’s largest event, the BIO International Convention . We hope the event was successful for everyone who attended. We know it was a busy time for folks, especially based on the numbers from ... [Published I Am Biotech - May 21 2013]

Entities: Beijing, Dave Thomas, Renewable Chemicals, San Francisco (United States)

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Time Magazine Modifies the Endless Debate Over GM Crops

Bryan Walsh wrote for Time magazine about the so-called “obsession” surrounding genetically modified (GM) crops: To environmentalist opponents, GM foods are simply evil, an understudied, possibly harmful tool used by big agribusiness to control ... [Published I Am Biotech - May 20 2013]

Entities: Genetically Modified Crops, Genetically Modified Foods, Agriculture, Genetically Modified, Sustainment

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Bringing Biotech to Boats at BIO World Congress

At the 2013 BIO World Congress on Industrial Biotechnology in Montreal next month you’ll be able to see a Campion boat on the exhibit show floor. “What will a boat be doing on the show floor of an industrial biotech conference?” you may ask. Well, ... [Published I Am Biotech - May 17 2013]

Entities: Biotechnology, Resin, Montreal, Industrial Biotechnology Corporation

First reported May 16 2013 - Updated May 17 2013 - 1 reports

FDA Food & Drug Administration

Act Now to Protect Public Health and Prepare for the Upcoming Flu Season

As many as 49,000 people die from the flu annually, depending on the season, and children and the elderly are the most vulnerable. Among the 138 children who died from the flu during the 2012-2013 season, the Centers for Disease Control and Prevention ... [Published I Am Biotech - May 16 2013]

Entities: Vaccine, Influenza, Public Health, FDA Food & Drug Administration, Centers for Disease Control and Prevention

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Only 12% of Public Biotechs are Profitable

Only 12% of Public Biotechs are Profitable Of the 286 biotech companies trading on public exchanges today, 241 focus on drug development, a slight drop in numbers from last year.* Of these 241 in the biopharmaceutical space, only 28 (12%) had both ... [Published I Am Biotech - May 16 2013]

Entities: Regeneron, Vertex, Acquisition

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Breakthrough Designations Reach 13

One of the outcomes of the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA) was the creation of the “Breakthrough Therapy” designation. The new law allows FDA to grant a Breakthrough Therapy designation to drugs showing early clinical ... [Published I Am Biotech - May 15 2013]

Entities: FDA Food & Drug Administration, Epidermolysis Bullosa, Vertex

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Canada Patent Utility: Former USPTO Director Interview at BIO Convention

David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and Moore, LLP discusses the Canadian Utility Requirement. ... [Published I Am Biotech - May 13 2013]

Entities: United States Patent And Trademark Office, Patent, Canada

First reported May 09 2013 - Updated May 09 2013 - 1 reports

“Time to Call out the Anti-GMO Conspiracy Theory”

In a speech last week at Cornell University on anti-GMO conspiracy theory, Mark Lynas told audiences “millions, possibly billions, of people have come to believe what is essentially a conspiracy theory, generating fear and misunderstanding about ... [Published I Am Biotech - May 09 2013]

Entities: Mark Lynas, Conspiracy, Oxford Farming Conference, Cornell University

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Five Countries, One Goal: Collaboration with Global Impact in the Life Sciences Industry

During the 2013 BIO International Convention , the Massachusetts Life Sciences Center (MLSC) and regions from four other countries launched the new International Collaborative Industry Program (ICIP). The MLSC will partner with Victoria , Australia; ... [Published I Am Biotech - May 03 2013]

Entities: Global Impact, Life Science, collaboration

More Content

sort by: Date \| Relevance
Innovative Companies and Investment Trends in C... [Published I Am Biotech - 20 hours ago]
Roundtable Discussion Highlights Innovation, Co... [Published I Am Biotech - May 22 2013]
Gene Patents, Angelina Jolie, and Reality [Published I Am Biotech - May 21 2013]
BIO Convention Post-Con, Plus a Look Ahead [Published I Am Biotech - May 21 2013]
Time Magazine Modifies the Endless Debate Over ... [Published I Am Biotech - May 20 2013]
Bringing Biotech to Boats at BIO World Congress [Published I Am Biotech - May 17 2013]
Only 12% of Public Biotechs are Profitable [Published I Am Biotech - May 16 2013]
Act Now to Protect Public Health and Prepare fo... [Published I Am Biotech - May 16 2013]
Breakthrough Designations Reach 13 [Published I Am Biotech - May 15 2013]
Canada Patent Utility: Former USPTO Director In... [Published I Am Biotech - May 13 2013]
“Time to Call out the Anti-GMO Conspiracy Theory” [Published I Am Biotech - May 09 2013]
Five Countries, One Goal: Collaboration with Gl... [Published I Am Biotech - May 03 2013]
Inside Health Policy: Clearing Up Confusion Sur... [Published I Am Biotech - Apr 30 2013]
What OxyContin Tells Us About the Value of “Eve... [Published I Am Biotech - Apr 29 2013]
Biopharmaceuticals and Accountable Care Organiz... [Published I Am Biotech - Apr 29 2013]
BioGENEius – From Student Participant to Judge [Published I Am Biotech - Apr 25 2013]
How to Drive International Innovation: Scientif... [Published I Am Biotech - Apr 25 2013]
RFS Under Fire: History, Significance and Curre... [Published I Am Biotech - Apr 25 2013]
The Affordable Care Act is Here to Stay [Published I Am Biotech - Apr 25 2013]
Debt, Taxes and Politics: Is There a Way Out? [Published I Am Biotech - Apr 25 2013]
Neal Carter on Ag Biotech: It’s Not An Experime... [Published I Am Biotech - Apr 25 2013]
Spotlight on China [Published I Am Biotech - Apr 25 2013]
The Rise of Specialty Pharmaceuticals [Published I Am Biotech - Apr 24 2013]
State of the Biotech Industry: Burrill’s Biotec... [Published I Am Biotech - Apr 24 2013]
Ag Biotech: Going on the Offense [Published I Am Biotech - Apr 24 2013]
Scientific American Worldview [Published I Am Biotech - Apr 24 2013]
Think Organic Farming is Better for the Environ... [Published I Am Biotech - Apr 24 2013]
Protect Yourself from a Hack Attack [Published I Am Biotech - Apr 24 2013]
The Ethics of the Market Access Debate [Published I Am Biotech - Apr 24 2013]
Managed Entry Trumps Risk Sharing [Published I Am Biotech - Apr 24 2013]

Blogs

sort by: Date \| Relevance
Innovative Companies and Investment Trends in C... [Published I Am Biotech - 20 hours ago] A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 as deals are happening and attractive returns are generated. According to Reuters, “biotech IPOs have turned in a strong performance, delivering an average return of ...
Roundtable Discussion Highlights Innovation, Co... [Published I Am Biotech - May 22 2013] Last week BIO brought together representatives from five renewable chemical companies that will be speaking at BIO’s World Congress on Industrial Biotechnology next month in Montreal for a roundtable discussion highlighting developments in the renewable ...
Gene Patents, Angelina Jolie, and Reality [Published I Am Biotech - May 21 2013] By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Angelina Jolie recently announced her personal connection with breast cancer and Myriad’s BRCA genetic test. While Jolie’s post was a ...
BIO Convention Post-Con, Plus a Look Ahead [Published I Am Biotech - May 21 2013] Last month, the biopharma community gathered for the industry’s largest event, the BIO International Convention . We hope the event was successful for everyone who attended. We know it was a busy time for folks, especially based on the numbers from ...
Time Magazine Modifies the Endless Debate Over ... [Published I Am Biotech - May 20 2013] Bryan Walsh wrote for Time magazine about the so-called “obsession” surrounding genetically modified (GM) crops: To environmentalist opponents, GM foods are simply evil, an understudied, possibly harmful tool used by big agribusiness to control ...